Sold by: Next Move Strategy Consulting
Deployed on AWS
The forecast for the global Neuromodulation Market indicates it is poised to reach $22 Billion by 2030, with a Compound Annual Growth Rate (CAGR) of 13% from 2023 to 2030. The rising incidence of neurological disorders worldwide is driving the need for enhanced healthcare infrastructure and innovative treatment methods for managing such conditions. Consequently, this surge in demand is fueling the expansion of the global neuromodulation market.
Overview
The projected value of the worldwide Neuromodulation Market is expected to hit $22 Billion by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 13% from 2023 to 2030. Neuromodulation is controlled electric stimulation of the central nervous system or the peripheral nerve, to manage neural activity in patients suffering from neurological disorders such as cerebrovascular diseases, Alzheimer's disease, epilepsy, Parkinson's, and those caused by bacterial, viral, and fungal infections. The electrodes are directly placed in the brain's peripheral nerves or spinal cord, and pulse generators are implanted under the skin for better results.
The increasing prevalence of neurological disorders worldwide augments the demand for proper healthcare facilities and advanced treatment options to cope with such conditions. Consequently, this drives the growth of the global neuromodulation market.
Request a FREE sample of the report, here, https://www.nextmsc.com/neuromodulation-market/request-sample
However, factors such as strict policies for product approval and the need for more skilled healthcare professionals are expected to impede the market's growth.
Moreover, factors such as the increasing geriatric population, which is more prone to neurological disorders, growing awareness regarding the safety and efficiency of neuromodulation techniques, and increasing investments by both public and private sectors in clinical research and development activities for technological advancements, are expected to foster the growth of the global neuromodulation market throughout the forecast period.
Inquire before buying, here, https://www.nextmsc.com/neuromodulation-market/inquire-before-buying
The global neuromodulation market share has been analyzed based on technology, application, biomaterial, and geography.
Based on technology, the neuromodulation market is classified into internal neuromodulation and external neuromodulation. The internal neuromodulation segment is sub-segmented into Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Spinal Cord Stimulation, and others. The external neuromodulation segment is further divided into Transcutaneous Electrical Nerve Stimulation and Transcranial Magnetic Stimulation.
Based on application, the neuromodulation market is fragmented into chronic pain management, failed back syndrome, epilepsy, tremor, urinary and fecal incontinence, depression, dystonia, gastroparesis, Parkinson's disease, Obsessive-Compulsive Disorder, migraine, and others.
Based on biomaterials, the neuromodulation market is divided into metallic biomaterials, polymeric biomaterials, and ceramic biomaterials.
Geographic breakdown and analysis of each previously mentioned segment include regions comprising North America, Europe, Asia-Pacific, and RoW.
Access the full report, here, https://www.nextmsc.com/report/neuromodulation-market
North America is expected to dominate the global neuromodulation market throughout the forecast period. This is primarily attributed to its well-established healthcare infrastructures and medical laboratories, as well as the heightened prevalence of neurological disorders. These factors drive greater adoption of neuromodulation technologies and contribute to the increase in clinical trials aimed at technological advancements.
On the other hand, Asia Pacific is projected to witness significant growth in the global neuromodulation market, with a substantial increase in market share expected over the forecast period. This growth can be attributed to the rise in government initiatives aimed at addressing chronic neurological disorders, as well as the growing number of product launches in the region.
The neuromodulation market is highly competitive and consists of various market players. Some of the major market players include Abbott, Medtronic, Boston Scientific Corporation, Cochlear Ltd., Cyberonics Inc., Sonova, Nevro Corp., Advanced Bionics AG, Integer Holdings Corporation, Neuronetics, NeuroPace Inc., Synapse Biomedical Inc., Magstim, NeuroSigma Inc., LivaNova PLC, Soterix Medical Inc., ALEVA NEUROTHERAPEUTICS SA, ReShape Lifesciences Inc., Bioness Inc., DynaMD, BioAlps, MED-EL, The Axonics SNM System, Johnson & Johnson Services Inc., LABORIE, Stimwave LLC, Functional Neuromodulation Ltd., and Biegler GmbH among others.
An upsurge in R&D activities and advancement in product technologies along with an increasing number of FDA approvals stimulate the growth of the global neuromodulation market.
Details
Delivery method
Deployed on AWS
New
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Features and programs
Financing for AWS Marketplace purchases
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
Pricing
This product is available free of charge. Free subscriptions have no end date and may be canceled any time.
Additional AWS infrastructure costs may apply. Use the AWS Pricing Calculator to estimate your infrastructure costs.
Dimensions summary
This listing offers a single pricing dimension: Product Access, measured in Units. You get access to the market research report at no cost. There are no tiers, instance sizes, or usage add-ons to choose from. Access is granted to subscribers under this one option. The report is delivered digitally after purchase confirmation, typically within 24 to 48 hours, via email or a download link. Because this is a free listing, pricing does not scale with volume or usage.
Top-of-mind questions for buyers
One unit of Product Access grants a subscriber access to the neuromodulation market research report. The unit maps to a single license to view and use the digital report. Access is granted at no cost through this listing, so no per-user or volume counting affects your bill.
The report is delivered digitally in PDF, Excel, or Word format. You receive it via email or a download link at your registered email address. Delivery happens within 24 to 48 hours of payment confirmation. Customized reports follow a timeline shared based on scope and complexity.
No. All sales are final once the report is delivered. The vendor does not accept cancellations, returns, or refunds after a report is dispatched. Because the report is digital and contains sensitive research data, buyers are advised to review all terms carefully before acquiring access.
www.nextmsc.com+1
Helpful?
Vendor refund policy
Not applicable - product available free of charge.
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA) .
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Additional details
You will receive access to the following data sets.
Data set name | Type | Historical revisions | Future revisions | Sensitive information | Data dictionaries | Data samples |
|---|---|---|---|---|---|---|
NMSC_MarketResearch | All historical revisions | All future revisions | Not included | Not included |
Resources
Vendor resources
Similar products
60-minute live analyst briefing focused on the Pain Management Devices Market. Gain actionable market intelligence, healthcare technology insights, and AWS-aligned recommendations to optimize procurement, digital health strategy, product innovation, and cloud infrastructure planning.
The Pain Management Devices Market represents a vital sector in healthcare innovation projected to expand from USD 7.57 billion in 2025 to USD 12.07 billion by 2030 at a compound annual growth rate of 9.78 percent. This growth is propelled by the rising incidence of chronic diseases an aging global population and advancements in artificial intelligence integrated therapies.